• Opening Hours: Monday-Friday (8:30am-5:30pm), Saturday (8:30am-12:30pm), Closed on Sunday & Public Holiday


Seasonal Flu Vaccination is now available at our Medical Centre!

The flu vaccine is the best way to protect yourself from influenza. It is recommended for anyone 6 months and older.
The seasonal flu vaccine provides protection against the 4 strains of flu viruses that are expected to be the most common in the coming flu season.
Use of the vaccine reduces both the risk of catching the flu, and the risk of complications from the flu.

NOTICE: Our clinic stocks the INFLUVAC flu vaccine from ABBOTT. This use of this vaccine remains approved by Ministry of Health (MOH) and the Health Sciences Authority (HSA).

The affected vaccines that have been suspended from use are SKYCellflu Quadrivalent, manufactured by SK Bioscience and locally distributed by AJ Biologics; and VaxigripTetra, manufactured by Sanofi Pasteur and locally distributed by Sanofi Aventis.

Click here to know more.

Varian Receives Investigational Device Exemption (IDE) and Prepares for First Ever Clinical Trial of FLASH Therapy

Varian (NYSE: VAR) today announced the company has received an Investigational Device Exemption (IDE) from the Food and Drug Administration (FDA) for the first-ever clinical trial of FLASH therapy, an experimental treatment modality delivering radiation therapy at ultra-high dose rates. FLASH therapy, involving ultra-high dose rates, and delivery in typically less than one second, may be over 100 times faster compared to conventional radiation therapy.

Read the full article here


Date & Time: 10 October 2020, 10am
Speakers: Dr Robert Malyapa

Dr Malyapa is a radiation oncologist with over 20 years of experience. He subspecialises in Central Nervous System, Head and Neck and Paediatric Radiation Oncology and is currently the Director of Proton Therapy at Proton Therapy Pte Ltd, Singapore.

Please Click here for more webinar information.

Bringing Enhanced Cancer Care to Singapore with Varian's Halcyon System

Varian (NYSE: VAR) today announced that Proton Therapy Pte. Ltd. has placed an order for a Halcyon system, making them the first to bring this innovative treatment platform into Singapore, with the aim of treating the first patient by the end of the year.

Dr. Djeng Shih Kien, chairman, Proton Therapy Pte. Ltd. said: "We are proud to be at the forefront of bringing new technology into Singapore. Radiation therapy has a huge role to play in fighting the ever-growing number of cancer cases in this country and region. By harnessing the technology of Halcyon, we will be able to automate, streamline, and simplify virtually every aspect of treatment. This means we can offer more precise, efficient treatments when compared to conventional machines, while being able to improve patients' comfort by operating in a patient-centric environment."

Click here to read full article.

New Addition of Medical Services to the AM Medical Centre, Singapore.

We are happy to introduce the latest addition of medical services at the AM Medical Centre, Singapore! We provide a range of family medicine and health screening services to better serve your needs.

Starting 1st Sept 2020, the addition of medical services includes:
- GP Consultation
- Executive Health Screening
- Chronic Disease Management
- Full Imaging Services
- Laboratory Services
- Vaccination

For enquiries, please write to us at medicalcentre@advancedmedicine.sg or call our clinic at 6708 7888.

Multimodality Brain Tumour Imaging: MRI & FET-PET

Date & Time: 29 May 2020, 1pm
Speakers: Dr Damian Khor Lih Kin & Dr Eric Ting

This talk will discuss on molecular imaging with positron emission tomography (PET) and the new advanced MRI techniques, which permit noninvasive tumour characterization, and a more targeted therapeutic approach, with the goal of ultimately improving prognosis. While MRI remains the mainstay technique for brain tumoursimaging, PET complements MRI in addressing those questions that remain unanswered, such as lesion grading, tumour extent delineation and treatment response evaluation, amongst the many.

Please click here to watch the webinar

The Role of Imaging in the Diagnosis of Primary Prostate Cancer

Date & Time: 28 May 2020, 1pm
Speaker: Dr Gan Yu Unn

Multiparametric Prostate MRI (mpMRI) has taken a prominent role in the diagnostic pathway of prostate cancer management in recent years. This i due to advances in scanner technology, image sequences and quality. Imaging is utilised at the pre biopsy, pre and post treatment stages of prostate cancer management.

Please click here to watch the webinar
Please click here to review Webinar Event Q & A.